1-2 of 2
Charlotte Doublet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

18-Months Follow-up of the Trial of Imatinib after Ponatinib Induction (TIPI) in the Front-Line Treatment of Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Setting

Franck E. Nicolini, Aude Charbonnier, Martine Escoffre-Barbe, Eric Jourdan, Gabrielle Roth-Guepin, Marc G. Berger, Shanti Ame, Marion Simonet, Hyacinthe A Johnson-Ansah, Viviane Dubruille, Amandine Charbonnier, Philippe Rousselot, Corentin Orvain, Bertrand Joly, Jean-Christophe Ianotto, Emilie Cayssials, Mathieu Meunier, Anne Parry, Valerie Coiteux, Laurence Legros, Hacene Zerazhi, Gabriel Etienne, Philippe Quittet, Ollivier Legrand, Amelie Penot, Lydia Roy, Charlotte Doublet, Stéphane Morisset, Romaine Mayet, Gwenaëlle Garin, Stéphanie Dulucq, Françoise Huguet
Journal: Blood
Blood (2024) 144 (Supplement 1): 478.
https://doi.org/10.1182/blood-2024-198903
Published: 2024
Journal Articles

Safety and Efficacy of Venetoclax-Based Treatment in Elderly CLL Patients: A Retrospective Study from the Filo Group

Charlotte Doublet, Marie-Sarah Dilhuydy, Emmanuelle Ferrant, Pierre Feugier, Alexandra Fayault, Philippine Robert, Stephane Lepretre, Alain Delmer, Cécile Tomowiak, Romain Guieze, Kamel Laribi, Marguerite Vignon, Aline Clavert, Fontanet Bijou, Daniel Re, Diane Lara, Fatiha Merabet, Emmanuelle Tchernonog, Caroline Dartigeas, Anne-Sophie Michallet, Anne Quinquenel
Journal: Blood
Blood (2021) 138 (Supplement 1): 3747.
https://doi.org/10.1182/blood-2021-149640
Published: 2021